These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20592006)

  • 1. Advisor-Teller Money Manager (ATM) therapy for substance use disorders.
    Rosen MI; Rounsaville BJ; Ablondi K; Black AC; Rosenheck RA
    Psychiatr Serv; 2010 Jul; 61(7):707-13. PubMed ID: 20592006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways to assignment of payees.
    Rosen MI; Ablondi K; Black AC; Serowik KL; Rowe M
    Community Ment Health J; 2014 Apr; 50(3):270-4. PubMed ID: 23765182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of a money management-based substance use intervention.
    Rosen MI; Carroll KM; Stefanovics E; Rosenheck RA
    Psychiatr Serv; 2009 Apr; 60(4):498-504. PubMed ID: 19339325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A money management-based substance use treatment increases valuation of future rewards.
    Black AC; Rosen MI
    Addict Behav; 2011; 36(1-2):125-8. PubMed ID: 20826055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial Capability: Clinicians' Assessment of Beneficiaries With Dual Diagnoses.
    Thornhill Iv TA; Black AC; Rosen MI
    J Dual Diagn; 2018; 14(2):130-136. PubMed ID: 29505348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance abuse and the need for money management assistance among psychiatric inpatients.
    Rosen MI; Rosenheck RA; Shaner AL; Eckman TA; Gamache GR; Krebs CW
    Drug Alcohol Depend; 2002 Aug; 67(3):331-4. PubMed ID: 12127204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does assigning a representative payee reduce substance abuse?
    Rosen MI; McMahon TJ; Rosenheck R
    Drug Alcohol Depend; 2007 Jan; 86(2-3):115-22. PubMed ID: 16839710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Veterans who may need a payee to prevent misuse of funds for drugs.
    Rosen MI; Rosenheck RA; Shaner A; Eckman T; Gamache G; Krebs C
    Psychiatr Serv; 2002 Aug; 53(8):995-1000. PubMed ID: 12161675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes.
    McKay JR; Lynch KG; Shepard DS; Pettinati HM
    Arch Gen Psychiatry; 2005 Feb; 62(2):199-207. PubMed ID: 15699297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating primary medical care with addiction treatment: a randomized controlled trial.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Lu Y
    JAMA; 2001 Oct; 286(14):1715-23. PubMed ID: 11594896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated with Money Mismanagement Among Adults with Severe Mental Illness and Substance Abuse.
    Moore BA; Black AC; Rosen MI
    Int J Ment Health Addict; 2016 Aug; 14(4):400-409. PubMed ID: 29456461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing disability benefits as part of treatment for persons with severe mental illness and comorbid drug/alcohol disorders. A comparative study of payee and non-payee participants.
    Ries RK; Comtois KA
    Am J Addict; 1997; 6(4):330-8. PubMed ID: 9398931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of self-reported drug use in chronic pain patients.
    Fishbain DA; Cutler RB; Rosomoff HL; Rosomoff RS
    Clin J Pain; 1999 Sep; 15(3):184-91. PubMed ID: 10524471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
    Klimas J; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
    Cochrane Database Syst Rev; 2014 Dec; (12):CD009269. PubMed ID: 25470303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expenditures of time and money by families of people with severe mental illness and substance use disorders.
    Clark RE; Drake RE
    Community Ment Health J; 1994 Apr; 30(2):145-63. PubMed ID: 8013212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disability payments, drug use and representative payees: an analysis of the relationships.
    Swartz JA; Hsieh CM; Baumohl J
    Addiction; 2003 Jul; 98(7):965-75. PubMed ID: 12814502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective Experiences of Clients in a Voluntary Money Management Program.
    Serowik KL; Bellamy CD; Rowe M; Rosen MI
    Am J Psychiatr Rehabil; 2013; 16(2):136-153. PubMed ID: 24605071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring money mismanagement among dually diagnosed clients.
    Black RA; Rounsaville BJ; Rosenheck RA; Conrad KJ; Ball SA; Rosen MI
    J Nerv Ment Dis; 2008 Jul; 196(7):576-9. PubMed ID: 18626300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.